Two mergers and acquisitions partners from A&O Shearman have made the jump to White & Case, joining the international firm’s corporate team in Sydney.
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
The corporate regulator has warned financial services and credit licensees to get ahead of the curve in regulating the use of AI, particularly in the face of novel risks that include algorithm bias.
Homes Victoria says the decision to demolish public housing towers in Melbourne — now the subject of a class action — took residents’ human rights into account, but has no documents to show it.
Former radio host Antoinette Lattouf will argue at trial that the ex-chair of the ABC, Ita Buttrose, and managing director David Anderson were involved in the decision to terminate her contract.
Clive Palmer’s nephew has applied to the High Court for review of a decision rejecting his bid to dodge contempt proceedings, arguing he did not submit to the court’s jurisdiction.
HFW has secured the expertise of a construction disputes specialist, set to join its Perth office in November from Clifford Chance.
A ‘junk’ insurance class action against Suncorp unit AAI wants an initial trial to deal with the claim — absent a sample group member — that car dealers made purchasing a policy necessary for a loan.
Ashurst has launched a new risk consultation division designed to provide end-to-end support for clients undergoing major transformations, luring three partners from competitors to head it up.